Sylvie Zini

Identification of metabolic pathways of brain angiotensin II and III using specific aminopeptidase inhibitors: predominant role of angiotensin III in the control of vasopressin release.

Sylvie Zini, M.-C. Fournié-Zaluski, Eric N. Chauvel et al. · Proceedings of the National Academy of Sciences · 1996 · 319 citations

Medicine, Neurobiology, Pharmacology +15

Aminopeptidase A inhibitors as potential central antihypertensive agents

Annabelle Réaux‐Le Goazigo, Marie Claude Fournié-Zaluski, Christelle David et al. · Proceedings of the National Academy of Sciences · 1999 · 193 citations · Full text

Medicine, Neurobiology, Pharmacology +15

Galanin reduces release of endogeneous excitatory amino acids in the rat hippocampus

Sylvie Zini, Marie‐Paule Roisin, Ülo Langel et al. · European Journal of Pharmacology Molecular Pharmacology · 1993 · 163 citations

Life Sciences, Neurobiology, Neuroscience +14

PC18, a Specific Aminopeptidase N Inhibitor, Induces Vasopressin Release by Increasing the Half-Life of Brain Angiotensin III

Nadia De Mota, Sylvie Zini, Sandrine Cadel et al. · Neuroendocrinology · 1999 · 81 citations

Medicine, Neurobiology, Pharmacology +13

Effect of potassium channel modulators on the release of glutamate induced by ischaemic-like conditions in rat hippocampal slices

Sylvie Zini, Marie-Paule Roisin, Catherine Armengaud et al. · Neuroscience Letters · 1993 · 71 citations

Life Sciences, Neurobiology, Neuroscience +16